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The finding that the heterologous expression of Bcl-2 proteins in yeast elicits effects that resemble their roles in metazoan apoptosis has
contributed to the increasing use of this organism as a model for the study of apoptotic regulation. The pro-apoptotic Bax protein, for example,
localizes to the yeast mitochondria, where it acts to promote alterations in mitochondrial physiology and cell death, similar to its ascribed mode of
action in higher organisms. These observations lead to the hypothesis that the heterologous Bcl-2 proteins impinge on conserved elements of the
apoptotic machinery in yeast. We herein provide a retrospective of the studies aimed at both testing this general hypothesis and investigating the
mechanisms of the Bcl-2 proteins using yeast, with a particular emphasis on Bax. We also discuss the evidence for pleiotropic roles of Bax in yeast
apoptosis.
© 2008 Elsevier B.V. All rights reserved.Keywords: Bax; Bcl-2 protein; Yeast apoptosis1. Introduction: The Bcl-2 family members are critical
regulators of apoptosis
Apoptosis is a genetically programmed form of cell death
that is important for the survival of multicellular organisms by
virtue of its functions in eliminating damaged or infected cells
[1–4]. Further, loss of normal apoptotic responses can lead to
uncontrolled cell growth, contributing to the development of
tumours [5]. A number of single cell organisms, including the
yeast Saccharomyces cerevisiae, have been shown to undergo
programmed cell death (PCD) [6,7]. Given that yeast cells have
been used extensively to understand the framework of a number
of basic biological systems [8], it stands to reason that our
understanding of PCD should therefore be greatly enhanced
by the current studies of PCD in yeast. Although initially
controversial, there is now very little doubt that yeast PCD is
similar to the process of intrinsic apoptotic cell death that occurs
in mammalian cells [9,10]. This is exemplified by the fact that
the yeast genome encodes for a number of orthologous genes
that have been shown to be important in mammalian apoptosis.⁎ Corresponding authors.
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doi:10.1016/j.bbamcr.2007.12.013Yeasts have an AIF (Apoptosis Inducing Factor AIF), metacas-
pase (YCA1), an IAP (inhibitor of Apoptosis Protein; BIR1),
OMI/Htr2A (Nuclear Mediator of Apoptosis; NMA111), DJ-1
(HSP31) as well as a nuclease (TAT-D) that is a strong candidate
to be involved in DNA degradation during apoptosis [11–15].
As in metazoans, overexpression of the apoptotic proteins can
serve to initiate or enhance cell death in yeast, while strains
lacking any of these genes show a decreased response to a
number of different death stimuli.
Members of the Bcl-2 family of proteins (n≥22) are im-
portant regulators of the metazoan apoptotic process [16]. They
are divided into subfamilies based on their apoptotic and anti-
apoptotic nature as well as the presence or absence of different
Bcl-2 Homology (BH) domains [17,18]. Bcl-2 contains all four
BH domains and is a widely studied member of the Bcl-2 anti-
apoptotic subfamily. Bax is the best-studied member of the pro-
apoptotic Bcl-2 proteins that contain multiple BH domains.
In response to pro-apoptotic stimuli, members of the Bax-like
protein family act on the mitochondria to induce changes such as
the release of cytochrome c (cyt c) [17–19]. Many additional
BH-domain containing proteins have been studied to lesser
degrees, including the pro-apoptotic Bad, Bak, and Bim, among
others, as well as the anti-apoptotic Bcl-xL, BFL-1 (A1), Mcl-1,
and CED-9 [17,20].
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evidence suggests that the complete functional repertoire of Bax
and Bcl-2 is not well understood [16]. Although yeast do not
have genes encoding Bcl-2 proteins, the heterologous expres-
sion of mammalian Bax in yeast nevertheless induces a sup-
pressible lethal phenotype that is associated with characteristics
of metazoan apoptosis, including phosphatidylserine exter-
nalization, chromatin condensation, DNA breakage, and the
formation of apoptotic bodies (Table 1) [21]. Since the initial
demonstration that Bax is lethal when expressed in yeast,
numerous groups have used yeast as a model system to study
the function of Bax [22,23]. Studies have focused on different
facets of Bax that range from determining its structure/function,
to examining its role in mediating the effects on prions, to
determining how it interacts with the mitochondria to using the
lethal effects of Bax to screen for novel anti-apoptotic genes.
Here we will give a historical perspective of Bax in yeast and we
review the establishment of this model system as a powerful
platform for the study of the structural/functional/mechanistic
properties of Bax and other Bcl-2 family members. We also
present the current knowledge on the mechanisms by which
Bax promotes deleterious effects in yeast and discuss the use of
classical yeast-based approaches, such as functional suppres-
sor screens, to gain functional insights into the evolutionary
conserved process of apoptosis.
2. The establishment of yeast as a tool for functional studies
on Bax
2.1. Bax expression in yeast induces a programmed cell death
with apoptotic features
The initial observation that Bax expression confers a lethal
phenotype in yeast was made during the course of yeast two-Table 1
Bcl-2 and Bcl-2-related proteins and their reported effects in yeast
Phenotypes observed on isolated yeast mitochondria or upon heterologou
Pro-apoptotic Bcl-2 proteins
Bax Loss of mitochondrial membrane potential, and cytochrome c release. Induc
Elicits cell death upon expression in Schizosaccharomyces pombe.
Bad Sensitizes cells to the effects of Bax, yet was also reported to enhance the
Bak Loss of mitochondrial membrane potential. Induction of cell death upon e
Bcl-xS Enhances the pro-survival activity of Bcl-xL, Bcl-2, and A1.
Bim Loss of mitochondrial membrane potential, cytochrome c release and cell
BimS Sensitizes cells to the lethal effects of Bax.
BNip3 No effect observed.
BNip3L No effect observed.
Noxa No effect observed.
Puma Sensitizes cells to the effects of Bax.
tBid Disrupts mitochondrial state-3 respiration and ATP production. Sensitizes c
Anti-apoptotic Bcl-2 proteins
A1 Protects from Bax- and Bak-induced cytotoxicity.
Bcl-2 Promotes cell survival. Increases resistance to oxidative stresses.
Bcl-xL Prevents Bax-induced growth-inhibition and cell death. Increases resistan
BFL-1 Protects from Bax-induced cell death.
CED-9 Promotes resistance to oxidative stresses.
Mcl-1 Protects from Bax- and Bak-induced cytotoxicity.hybrid studies aimed at examining Bax/Bcl-2 interactions [24].
Expression of Bax fused to either DNA-binding or trans-
activation domains in yeast cells, under the control of a strong
promoter, resulted in marked loss of clonogenic capacity that
was confirmed to be due to cell death. Further, the effect was
specifically suppressed by co-expression of anti-apoptotic Bcl-2,
Bcl-xL, and Mcl-1, indicating that both pro- and anti-apoptotic
Bcl-2 family members retained certain aspects of their function
when heterologously expressed in yeast [24]. Subsequent
studies confirmed a lethal phenotype upon expression of Bax,
unfused and lacking a signal peptide, under the control of the
GAL1/GAL10 promoter [25]. These observations lead to the
hypothesis that the mammalian Bcl-2 proteins act on elements
of a conserved endogenous yeast machinery to mediate effects
on viability [26]. Importantly, Bax-mediated cell death in yeast,
as in mammalian cells, involves a regulated insertion into
mitochondrial membranes and mitochondrial dysfunction lead-
ing to the release of cyt c and apoptosis, supporting the
hypothesis that Bax exerts effects in yeast that are comparable
to those in its native setting [23].
A seminal study in the field of yeast apoptosis involved the
identification of typical markers of mammalian apoptosis in
cells mutated for CDC48 [27]. These findings strongly sug-
gested that the basic framework of apoptosis is conserved in
lower eukaryotes. The first description of apoptotic phenotypes
in yeast induced by members of Bcl-2 family involved the
expression of pro-apoptotic human Bak in Schizosaccharo-
myces pombe [28]. The specific phenotypes reported included
nuclear envelope breakdown and chromatin condensation and
fragmentation, which are characteristics of metazoan apoptosis.
The deleterious effects of Bak were dependent on the BH3
domain and suppressed by co-expression of Bcl-xL and Bcl-2,
but not by a mutant form of Bcl-2 that does not prevent
apoptosis in mammalian cells [29]. Shortly thereafter, similars expression in yeast. References
tion of oxidative stress, growth-inhibition, and cell death. [20,28,27,33,37,106]
pro-survival activity of Bcl-xL, Bcl-2 and A1. [44,167]
xpression in Schizosaccharomyces pombe. [26,27,37]
[37,167]
death. Enhances the death-inducing activity of Bax. [122,166]
[166]
[44]
[44]
[44]
[44]
ells to Bax-induced cytochrome c release and cell death. [43,44]
[37]
[33,37,51]
ce to oxidative stresses. [27,37, 106]
[168]
[51]
[37,165]
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cerevisiae were reported [30]. This report documented the
phenotypes of chromatin condensation, DNA breakage, plasma
membrane blebbing, as well as Annexin V-positive Bax-ex-
pressing cells, an indicator of the commonly observed metazoan
apoptotic phenomenon of phosphatidylserine externalization
[30]. While there has not been detection of DNA laddering, a
phenotype typically observed in apoptotic mammalian cells,
this has been proposed to be due to the marked distinctions in
heterochromatin structure and organization [31]. Nevertheless,
the findings by Ligr and others clearly indicate the appearance
of hallmarks of apoptosis upon Bax expression in yeast [21,30].
2.2. The lack of apparent Bcl-2 family member orthologs in
yeast has facilitated their functional analysis
The evidence described above suggesting that Bcl-2 fa-
mily members impinge on conserved molecular components
prompted a number of groups to study the function of these
metazoan regulators of apoptosis in yeast. Importantly, yeast
lack apparent orthologs of metazoan Bcl-2 family members [32].
Heterologous expression of these proteins in yeast therefore
allows the study of their mechanisms of action in the absence of
the network of Bcl-2 apoptotic regulators present in metazoans.
This fact has facilitated the study of individual Bcl-2 proteins,
since the presence of alternate endogenous forms of Bcl-2 fa-
mily members with conflicting or redundant functions often
makes interpretation of a given experiment problematic [16]. For
instance, the demonstration that pro- and anti-apoptotic Bcl-2
proteins are able to interact leads to the hypothesis that he-
terodimerization represents a major regulatory mechanism
between these proteins [24,33]. However, a mutant form of
Bcl-xL which is unable to bind Bax retains the ability to pre-
vent the deleterious effects of Bax in yeast [34]. Therefore, the
finding that individual Bcl-2 family members retain their pro- or
anti-apoptotic functions when expressed in yeast strongly sug-
gested heterodimerization-independent functions of these pro-
teins [34,35]. These findings are consistent with descriptions
of autonomous functions for Bcl-2 proteins in both yeast and
mammalian cells, such as pro-survival effects due to an intrin-
sic anti-oxidant function [36].
In light of their initial observations that Bax is lethal to
yeast, Reed et al. used this system to study the Bcl-2 family
members, including the structural determinants of Bax function
[37]. The interpretation of structure/function studies performed
in yeast-based systems has resolved many questions concern-
ing the regulation of metazoan apoptosis by the Bcl-2 family
[23,38]. In addition to providing the first evidence for he-
terodimerization-independent mechanisms by which both Bcl-2
and Bcl-xL prevent Bax-induced cell death [35,39], the func-
tional analysis of deletion mutants of the Bcl-2 protein lead to
the initial descriptions of the BH domains [35]. Mutants deleted
for the transmembrane domain (TMD) of Bcl-xL, but not of
Bcl-2 were unable to prevent Bax-induced cell death in yeast,
suggesting divergent mechanisms of action for the two pro-
teins [39]. Also, homodimerization-defective mutants of Bax
were shown to be ineffective in eliciting a lethal phenotype,suggesting a crucial role for homodimerization in the effects
of Bax [31]. Importantly, these findings were consistently
validated by studies in mammalian cells [34,40].
The Bcl-2-null genetic background was further exploited
in yeast engineered to allow the independent regulation of
expression levels of both pro- and anti-apoptotic Bcl-2 proteins
[41]. The level of a HA–Bcl-xL fusion (expressed under the
control of the inducible tetO promoter) sufficient to protect from
the effects of HA–Bax (expressed under the control of GAL1
promoter and maintained at constant levels) remained con-
stant over a wide range (30–40-fold difference) of HA–Bax
expression levels, suggesting that heterodimerization of Bcl-xL
with Bax is not required for the protective effects. Strongly
supporting this conclusion is the unaltered ability of a hete-
rodimerization-defective mutant form of Bcl-xL to prevent
the effects of Bax [41]. Further, increasing the expression of
HA–Bcl-xL to levels that were effective in preventing the lethal
effects of HA–Bax maintained at constant levels resulted in a
concomitant cytoplasmic accumulation of Bax. A quantitative
analysis indicated, however, that the amount of Bax that re-
mained inserted at the mitochondria was sufficient to induce
lethality, indicating a role for Bcl-xL in preventing effects of
membrane-integrated Bax [41].
Additional examples of lessons learned from the yeast-based
study of Bcl-2 proteins include the demonstration of a sti-
mulatory effect of a caspase-generated form of Bid (tBid) on
cell death and cyt c release induced by activated Bax [42,43].
However, this stimulatory effect of tBid was not observed
when co-expressed with the ground state Bax, demonstrating
that Bax activation (by a tBid-independent mechanism) pre-
cludes the stimulatory action of tBid [44]. In a subsequent
study, experiments using recombinant tBid incubated with
isolated yeast mitochondria confirmed findings that tBid dis-
rupts mitochondrial bioenergetics independent of other Bcl-2
family members [45].
Finally, Guscetti et al. carried out an expansive analysis
of pro-apoptotic BH3-only proteins in yeast, and established
three categories of such proteins based on their functional
characteristics: directly killing (tBid), those that sensitize Bax/
Bcl-2 expressing cells for death (Bad or puma), and BH3-only
proteins that display no toxicity (BNip3, BNip3L, and Noxa)
[46]. In a separate study, the BH3-only protein BimS,
previously hypothesized to promote apoptosis by inhibiting
anti-apoptotic Bcl-2 proteins, was demonstrated to enhance the
lethal effects of Bax in yeast, thereby arguing against a
dependency for other Bcl-2 proteins in BimS function [47].
These findings illustrate the usefulness of yeast in studying the
function of Bcl-2 family members by virtue of its ‘clean’ genetic
background.
2.3. Yeast as a model to study Bcl-2 proteins and their
relationship to other heterologous apoptotic regulators
2.3.1. Studies on the apoptotic regulatory molecules of
Caenorhabditis elegans in yeast
Seminal genetic studies by Horvitz et al. in Caenorhabditis
elegans resulted in the identification of important apoptotic
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[48]. CED-3 encodes for a caspase, while CED-4 and CED-9
represent orthologs of Apaf-1 and Bcl-2, respectively [49]. Fol-
lowing suite from the inducible yeast expression systems de-
veloped for the study of the Bcl-2 proteins [37,39], several
groups investigated the properties of theCaenorhabditis elegans
apoptotic proteins in yeast [50–53]. Early studies in Schizo-
saccharomyces pombe indicated the presence of endogenous
machinery responsive to the CED proteins [53]. The hetero-
logous expression of ced-4 resulted in the apoptotic phenotypes
of chromatin condensation and lethality, and these effects were
suppressed upon co-expression of ced-9. The heterologous ex-
pression of either ced-3 or ced-4 was subsequently shown to
result in lethality of Saccharomyces cerevisiae, in a manner
suppressible by ced-9 expression [50]. The killing activity of
CED-4 was dependent on its nucleotide triphosphate-binding
loop in both Saccharomyces cerevisiae and Schizosaccharo-
myces pombe, as it is in Caenorhabditis elegans, indicating a
specific mode of action for this protein in yeast [50,53]. Further,
these studies provided the evidence for a caspase/CED-3-inde-
pendent and CED-9-suppressible cell death pathway induced
by CED-4. Refuting this notion, a subsequent report describing
a reconstituted CED pathway in yeast indicated that CED-4
alone is insufficient to induce lethality, but rather that it pos-
sessed a stimulatory effect on CED-3-mediated cell death that
was suppressed by CED-9 [52]. Further, the pro-survival ef-
fect of CED-9 was not observed upon induction of cell death by
ced-3 expression alone. It should also be noted that, similar to
other anti-apoptotic Bcl-2 proteins, CED-9 has been demon-
strated to protect yeast from the lethal effects of oxidative stress,
suggesting an anti-apoptotic role independent of the CED pro-
tein network [54].
The yeast expression system was also employed to define the
interplay between Bcl-2 and the Caenorhabditis elegans apop-
totic machinery. Bcl-2 displays no inhibitory action on CED-4-
mediated lethality in yeast, arguing against the previously pro-
posed direct pro-survival role for Bcl-2 observed in Caenorhab-
ditis elegans and inmammalian cells ectopically expressing ced-3
and ced-4 [51]. Bcl-2 expression is, however, effective in bind-
ing to and displacing the pro-apoptotic Caenorhabditis elegans
protein EGL-1, suggesting an alternate mechanism for the ob-
served anti-apoptotic effects of heterologously expressed Bcl-2.
Based on these collective findings, yeast is clearly useful to
reconstitute heterologous apoptotic regulatory networks and con-
tinued work in this system will help delineate the complete
functions of the CED proteins in apoptosis.
2.3.2. Prions and Bax in yeast
More recently, Bax-induced cell death in yeast has been
exploited to perform genetic and functional analyses of
mammalian prion protein PrP [55,56]. Prior reports indicating
that the expression of the non-infectious PrPC form of the prion
protein suppresses the effects of Bax in cultured neurons [57]
prompted the examination of its effects on Bax-mediated cell
death in yeast. The expression of prion protein in yeast, which
is handled by the secretory pathway to produce a GPI-anchored
cell surface protein, rescued Bax-induced lethality [55,56]. Re-moval of the signal peptide and C-terminal membrane-
anchoring sequences from PrP prevented its suppressive
capability, suggesting that cytosolic PrP cannot prevent Bax-
induced cell death. However, a subsequent report demonstrated
Bax suppression by an expressing native, human PrP, which is
largely excluded from the secretory pathway because of the
weak nature of the heterologous signal peptide. Consistent with
observations in mammalian systems [58], these findings suggest
that cytosolic prion protein can suppress the effects of Bax.
Therefore, yeast is an amenable model system for the study of
mammalian proteins that functionally interact with Bax and can
lead to biological insights into the conserved Bax-mediated
mechanisms.
2.3.3. The use of Bax-expressing yeast cells to identify and
characterize novel anti-apoptotic proteins
The demonstration that Bax displays lethal functions in
yeast raised the prospect that suppressors of this phenotype that
represent putative anti-apoptotic factors could be identified by
functional screening strategies. Reed and co-workers initially
used this screening strategy and reported the isolation of Bax
inhibitor-1 (BI-1) from a human HepG2 hepatocarcinoma
cDNA library [59,60]. BI-1 is now a well-studied protein that
possesses anti-apoptotic activity across kingdoms [61]. In the
years succeeding this finding, a number of heterologous anti-
apoptotic proteins have been identifies by such strategies [62–
74]. This use of forward genetics provides not only information
regarding mechanisms of Bax-mediated metazoan apoptosis
through the identification of conserved metazoan anti-apoptotic
factors, but also offers mechanistic insight into the evolutiona-
rily conserved apoptotic and anti-apoptotic programme regu-
lated by Bax [26]. Similarly, classical genetic approaches have
been used to address the molecular requirements for Bax-
mediated cell death and on-going studies are likely to further
advance the knowledge on apoptotic mechanisms in yeast [75].
Below, we discuss some of the heterologous Bax suppressors
identified in phenotypic screens.
Bax is known to elevate ROS levels, and cellular responses
to such oxidative stresses include a robust attempt to counter
these elevations through a variety of mechanisms [76]. For
instance, cells commonly increase the expression of anti-
oxidant proteins that served to protect against increases in ROS
[76,77]. Examples of such proteins identified in Bax suppressor
screens include a plant Glutathione S-transferase/peroxidase, a
soybean ascorbate peroxidase, a tomato phospholipid hydro-
peroxide, and a glutathione peroxidase [65,69,78]. Further, a
VAMP protein isolated as another Bax suppressor was
demonstrated to function downstream of the Bax-induced
oxidative burst [68]. Collectively, these findings underscore
the central role of ROS in cellular responses to Bax (see also
Section 3.4) [21].
A human HepG2 cDNA library screen resulted in the iden-
tification of Bifunctional Apoptosis Regulator (BAR), a 450
amino acid protein containing a TMD, and RING finger and
Sterile AlphaMotif (SAM) domains [74]. Initial characterization
of deletion mutants of BAR allowed the prediction that the
mammalian anti-apoptotic effects are independent of the RING
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suggesting a role for membrane localization in the function of
BAR [74]. It was further shown that the SAM domain binds anti-
apoptotic Bcl-2 proteins, but not Bax, and is required for BAR-
mediated anti-apoptosis. Curiously, suppression of Bax-induced
lethality in yeast was also dependent on the SAM domain of
BAR. Given the absence of Bcl-2 family members in yeast,
this suggests a conserved SAM-dependent mechanism of anti-
apoptosis in yeast and warrants further investigation.
A subunit of the Ku protein complex with functions in non-
homologous DNA double-strand break repair was identified
as a suppressor of Bax in yeast and was found to prevent the
translocation of Bax to the mitochondria, thereby preventing
Bax-mediated apoptosis in mammalian cells [71]. This report
indicated an anti-apoptotic function for Ku70 protein in addition
to, and independent of, its role in DNA repair.
In screening for Bax suppressors, we identified the mouse
sphingomyelin synthase I (SMS1α) [73]. SMS1α is an ER-
localized protein that uses ceramide and phosphatidylcholine
to produce sphingomyelin and diacylglycerol (DAG).
Although the gene encoding SMS1 has only recently been
cloned [79,80], the enzyme has long been considered to be
anti-apoptotic due to its utilization of the pro-apoptotic
sphingolipid ceramide [81,82]. Ceramide levels are known to
increase in response to stress, analogously to ROS, and can
trigger a variety of intracellular signaling responses, including
apoptosis induced by prolonged elevations in ceramide levels
[82]. The heterologous expression of SMS1α in yeast also
conferred resistance to the deleterious effects of H2O2, heat,
and exogenously added C2-ceramide and PHS [73]. The latter
is a precursor used in the synthesis of phytoceramide (fungal
ceramide). These results suggest that in addition to inducing
an increase in ROS, Bax expression in yeast also leads to the
accumulation of phytoceramide. Overexpression of SMS1 has
been recently reported to be anti-apoptotic in mammalian cells
[83].
Our screen of a human heart cDNA library has led to the
identification of 72 different Bax suppressors. While a number
of the proteins identified, such as Hsp72, Hsp90β, and Suv3
were previously identified as being anti-apoptotic, the majo-
rity of the clones have not. For instance, an alternatively spliced
protein encoded by the human VPS24 gene, Vps24β has been
characterized as a strong anti-apoptotic sequence in yeast [67].
Interestingly, the previously characterized Vps24α is not anti-
apoptotic and functionally compliment the lack of yeast Vps24,
whereas Vps24β does not. Also, the Bax-suppressive function
of Vps24β is independent of a functional ESCRT pathway, of
which the yeast Vps24 is an essential component. These findings
suggest that the human VPS24 gene encodes for two func-
tionally distinct proteins: Vps24α that functions in the ESCRT
pathway, and Vps24β that suppresses the effects of Bax in yeast
through an as of yet unknown mechanism.
2.4. Effects of Bcl-2 family members in other yeasts
Deleterious effects of Bax expression have been reported
in other unicellular ascomycetes, including Candida albicans,Kluyveromyces lactis, and Schizosaccharomyces pombe
[84,85]. Extending the aforementioned studies involving Bak
expression in Schizosaccharomyces pombe are descriptions
that this apoptotic phenotype is associated with defects in cell
cycle progression and an accumulation of large vesicular
structures and that Bak-induced lethality is mediated partly
through an interaction with calnexin, a component of the ER
quality control apparatus [86]. Unexpectedly, expression of
Bax in Schizosaccharomyces pombe results in a slow growth
phenotype, not cell death. Also, while the effects of both Bax
and Bak are suppressible by co-expression of Bcl-2 and Bcl-
xL, co-expression of the anti-apoptotic adenoviral E1B 19K
protein suppresses only the Bak-induced phenotype, further
suggesting distinct mechanisms for Bax and Bak function. Of
note, the Schizosaccharomyces pombe genome encodes for the
BH3-only protein SpRad9 that promotes a Bcl-2 suppressible
apoptosis when expressed in mammalian cells [87]. Interest-
ingly, SpRad9 is a critical component of a complex of proteins
(the ‘9–1–1 complex’, comprised of Rad9p, Rad1p Hus1p)
that mediate DNA damage/replication checkpoint signaling
[88]. While a role for SpRad9 in yeast apoptosis has not been
demonstrated, the human Rad9 serves as a direct link between
cell cycle checkpoint control and apoptosis, suggesting a
worthwhile avenue of investigation in Schizosaccharomyces
pombe [89].
Bax expression also promotes cell death and the accumula-
tion of endogenous ROS in the yeast K. lactis [85]. Interestingly,
while the co-expression of Bcl-xL prevents the cytotoxic defects
of Bax, the levels of ROS were not diminished. This indicates
that elevated ROS in K. lactis does not necessarily result in cell
death and that the anti-oxidant functions are distinct from the
anti-apoptotic properties of Bcl-xL.
Expressing a synthetic, codon-optimized Bax-encoding se-
quence in the pathogenic yeast Candida albicans results in
growth-inhibition and lethality [84]. Interestingly, fusion of Bax
with eGFP resulted in a potentiated cell death response to Bax,
by virtue of a hampered proteolytic degradation of the fusion
protein. Visualization of this fusion protein indicated a mito-
chondrial localization of Bax. Further, Bax expression in Can-
dida albicans causes the translocation of mitochondria from
a spatially dispersed organization to a cluster in the perinu-
clear region. While this mitochondrial clustering phenotype
has not been observed in other yeasts, there are reports of such
effects in mammalian cells induced by pro-apoptotic stimuli,
such as TNF-α, trail, and ceramide [84].
Recently, it was demonstrated that Bax expression in the
hemibiotrophic plant pathogen Colletrichum gloeosporioides
induces cell death with apoptotic hallmarks, and that expressing
Bcl-2 prolonged lifespan and stress resistance [90]. In addition,
morphogenetic changes affecting the adaptive responses to en-
vironmental factors, such as mycelium growth, conidia produc-
tion and germination, as well as plant virulence, are modified by
the expression of Bcl-2 and Bax. These findings suggest that a
regulatory cross-talk exists between the endogenous apoptotic
machinery responsive to the Bcl-2 proteins and the molecules
that mediate various developmental stages in the Colletrichum
gloeosporioides life cycle.
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mitochondria
A central role for the mitochondria in Bax-mediated apop-
tosis has been clearly demonstrated in both metazoan and yeast
cells. Activated Bax localizes to the mitochondria and promo-
tes alterations in the mitochondrial membrane potential and
permeabilization of the outer mitochondrial membrane (OMM)
allowing the release of apoptogenic factors [91]. The extent to
which these are conserved in yeast is as of yet uncertain. Ne-
vertheless, there exist endogenous orthologs of metazoan genes
with similar roles in the apoptotic cascade. All the available
evidence suggests that heterologously expressed Bax protein
impinges on evolutionarily conserved elements to induce spe-
cific effects, and is therefore thought to be a useful tool to study
the regulation of the apoptotic response [23]. The demonstrated
ability of Bcl-2 family members to act in yeast as they do in a
native setting suggests that yeast possesses factors that perform
these functions (i.e. proteins that form pores in the OMM).
Interestingly, while sharing onlymodest similarities in sequence,
certain regulators of mitochondrial fission/fusion events with
roles in yeast apoptosis display pore-forming properties [92].
Further investigation should reveal whether these or other yeast
proteins represent functional orthologs of Bcl-2 family mem-
bers. Nevertheless, the study of Bax in yeast has provided much
insight into the role of Bax at the mitochondria [23]. We present
a review of these finding in the following sub-sections.
3.1. Mitochondrial targeting and attachment of Bax in yeast
Structure/function studies focused on the relationship bet-
ween the determinants of mitochondrial targeting of Bax and its
ability to confer phenotypes such as cyt c release or cell death.
An N-terminal region of Bax, containing the first alpha helix
(Ha1), serves as a signal required to address the protein to both
yeast and mammalian mitochondria [93]. The deletion of the
first 19 residues, comprising the Apoptosis-Regulating Target-
ing (ART) sequence of Bax enhanced the binding of Bax to the
yeast mitochondria, suggesting a role for this sequence in
cytosolic retention of the protein, as had been proposed by
prior studies in mammalian cells [94]. This is consistent with
findings that the naturally occurring Bax ψ, which lacks the
ART sequence, displayed constitutive mitochondrial localiza-
tion [93].
Immunofluorescence studies demonstrated that the mitochon-
drial localization of heterologously expressed Bax is dependent
on its C-terminal TMD [31]. The TMD was also required for the
cytotoxic effect observed, suggesting that mitochondrial targeting
ofBax is critical for its pro-apoptotic function. The behavior of the
wild type Bax protein was reconstituted in a mutant lacking the
TMD by replacing the missing domain with a TMD sequence
from Mas70p, a yeast mitochondrial outer membrane protein
[31]. Subsequent studies contrasted these findings, however, by
indicating that a His6-tagged Bax protein lacking the C-terminal
TM domain displayed no effect on cyt c release from per-
meabilized yeast spheroplasts and isolated mitochondria when
compared to full length Bax [95]. Also, an independent analysisdemonstrated that a mutant form of Bax lacking the C-terminal
domain retained its mitochondrial localization in yeast, as well
as the ability to confer a lethal phenotype [96]. Interestingly,
while the substitution of the C-terminal domain of Bax with the
homologous sequence from Bcl-xL did not impair the mitochon-
drial localization, it abrogated the deleterious effects of Bax. This
indicates that mitochondrial insertion is not sufficient for the
lethal effects of Bax. Supporting these findings, subsequent
mutagenesis of the C-terminal TM domain indicated that it is not
required for the insertion of Bax into yeast mitochondria [97].
This study instead revealed that specific mutations within this
domain conferred a more pronounced mitochondrial insertion
and cyt c release phenotype, suggesting an inhibitory role for the
domain with respect to these properties, similar to the N-terminal
ART sequence described above.
Cardiolipin is a mitochondria-specific phospholipid that is
required for the cooperative pore-forming functions of Bid and
Bax [98]. Analyses using cardiolipin-deficient strains of yeast
due to mutations in the cardiolipin synthase-encoding gene,
CRD1, have led to contrasting findings with regard to the role of
this lipid in Bax-mediated cell death. While one study indicated
that strains lacking CRD1 exhibited no difference in mitochon-
drial insertion of Bax as compared to wild type, a subsequent
study suggested that strain differences may account for these
discrepancies [99].
Studies in yeast were also carried out to determine the molecu-
lar targets of Bax at the mitochondria. The human Tom22p, a
component of the protein import complex translocase of the outer
membrane (TOM), was demonstrated to act as a mitochondrial
Bax receptor [100]. Independent evidence for this came from
diploid yeast strains heterozygous for TOM22 that displayed
reduced levels of Tom22p present at mitochondria. There was
also a significantly reduced level of Bax present in isolated mi-
tochondria from heterozygotes, when compared to wild type mito-
chondria, supporting the model that Tom22p anchors Bax at the
mitochondrial surface [100].
An investigation into the mechanisms of tcBid/Bax targeting
to the mitochondria revealed a critical role for components of
the TOM complex [43]. In contrast to the work involving
Tom22p discussed above [100], the domains of the OMM
exposed to the cytosol, including the cytosolic regions of
Tom22p, appear to be dispensible for the tcBid/Bax-induced cyt
c release. Also, as reported previously with regard to the effects
of Bax expression [99], the extent of cyt c release induced by
tcBid/Bax was unaltered by the deletion of the CRD1 gene,
indicating the cardiolipin-independent nature of the event. Of
further interest, tcBid/Bax failed to induce cyt c release from
mitochondria isolated from yeast expressing the temperature-
sensitive allele of the pore-forming TOM complex subunit
Tom40p in non-permissive conditions.
Finally, a recent study addressed the hypothesis that phos-
phorylation events of key serine residues mediate the con-
formational changes required for relocalization of cytosolic
Bax to mitochondria. Substitutions of serine residues within
consensus target sites for GSK3β, PKA, and Akt/PKB revea-
led the potential importance of the phosphorylation of these
residues in Bax activation upon induction of apoptosis [101].
1455C.M. Khoury, M.T. Greenwood / Biochimica et Biophysica Acta 1783 (2008) 1449–14653.2. Bax expression promotes the release of cytochrome c
A central event in Bax-mediated apoptosis is the release of
specific mitochondrial proteins from the intermembrane space
into the cytosol upon permeabilization of the outer mitochon-
drial membrane (OMM). A number of resident mitochondrial
proteins are detected in the cytosol of apoptotic cells, includ-
ing cyt c, Smac/Diablo, Omi/Htr2A, AIF, and EndoG [102].
These released proteins have specific roles in the execution of
the apoptotic programme. Omi/Htr2A, for instance, possesses a
serine protease activity that has been demonstrated to cleave
members of the Inhibitor of Apoptosis Protein (AIP) family,
including XIAP, and thereby promote apoptosis [102]. Cyt c is
the most extensively studied of these proteins. Upon its release,
cyt c forms the aptly named apoptosome complex in the cytosol
with caspase-9 and Apaf-1. This is essential for the activation
of caspase-3, the ‘executioner’ caspase that cleaves a number of
intracellular substrates [103].
Manon et al. first described the release of cyt c in yeast when
studying the mitochondrial effects of Bax expression in whole
cells, isolated mitochondria, and permeabilized spheroplasts
[104]. As in mammalian cells, the release of cyt c can also be
induced by other apoptotic stimuli. In yeast, these stimuli in-
clude acetic acid, human α-synuclein expression, and specific
apoptosis-inducing mutations in CDC48 [105–107], suggesting
that the release of cyt c is also central to the yeast apoptotic
programme.
While there are data suggesting a direct role of cyt c release
in the apoptotic response [105–108], Bax retains its ability to
kill yeast lacking cyt c [109], indicating the presence of alterna-
tive pathways through which Bax-induced cell death occurs.
Also, Bax-induced cell death has been reported to occur with
undetectable levels of cytosolic cyt c [110], and while a cyto-
chrome c–GFP fusion is not released by Bax-expression under
both fermentative and respiratory conditions, the endpoint of
death is still observed. Therefore, cyt c release is not essential for
Bax-mediated apoptosis in yeast [111]. Together, these results
suggest that Bax-induced cyt c release may be an important
apoptotic event, but that alternate pathways exist. This notion
is consistent with reports in mammalian cells indicating the
induction of apoptotic events independent of cyt c release
[112,113].
3.3. Mechanisms regulating the release of mitochondrial
factors in response to Bax expression
The release of mitochondrial factors is a crucial event during
apoptosis, and therefore the mechanisms regulating OMM
permeabilization are of continued interest to investigators.
Despite the persistence of a number of hypotheses that explain
OMM permeabilization, the steps leading to this event are
largely unresolved. Because the IMM and OMM are left largely
intact [23], Bax-induced OMM permeabilization is therefore
thought not to be simply the result of destruction of the
membranes due to excess mitochondrial swelling, as has been
proposed by some groups [23]. Bax expression is associated
with distinct alterations in mitochondrial structure and physiol-ogy, including a hyperpolarization of the IMM, matrix swelling,
an ultimate dissipation of the IMM potential, a disruption of
mitochondrial bioenergetics, and finally release of the afore-
mentioned apoptogenic factors [102]. However, conclusive evi-
dence on the sequence or temporal profile of these events, as
well as causal associations between them has remained elusive.
A distinct advantage of studying these phenomena in yeast is
that in this organism, mitochondrial function can be disrupted
while retaining cell viability, in contrast to higher eukaryotes,
thus facilitating genetic analyses on Bax-mediated mitochon-
drial alterations. In the following sub-sections we review what
is known regarding the Bax-induced release of yeast mitochon-
drial factors and discuss the studies in which the current mo-
dels mediating this release have been tested in yeast. The reader
is referred to additional recent reviews [23,102,114] for detailed
descriptions of the current models explaining Bax-mediated
OMM permeabilization in mammalian and yeast cells.
3.3.1. Bax expression induces mitochondrial changes in yeast
by acting on components of the permeability transition pore
complex
Early events associated with apoptosis include an increase in
the permeability of the IMM to solutes b1.5 kDa in size, the
mitochondrial permeability transition (MPT), and changes of
the mitochondrial membrane potential (ΔΨm), prompting the
uncoupling of the respiratory chain and release of apoptogenic
mitochondrial factors [114]. A number of findings suggest a
critical role for the permeability transition pore complex (PTPC)
in Bax-induced alterations of ΔΨm [115,116]. The PTPC is a
large protein complex that spans both the IMM andOMM, and is
comprised of the voltage dependent anion channel (VDAC), an
ADP/ATP carrier (or adenine dinucleotide transporter; ANT)
and cyclophilin D, as well as certain accessory factors [117].
While the precise role of the PTPC in Bax-induced apoptosis has
not been resolved, studies in whole yeast cells and isolated
mitochondria have indicated that the PTPC is required for Bax
function [23].
It should be noted, as described in the sections that follow,
that the role of specific PTPC components in Bax-mediated
apoptosis remains a matter of controversy, with conflicting
conclusions from different groups [23,109,118]. These distinct
effects of Bax expression have been proposed to be due to
differences in expression levels, different epitope tags fused
to the native Bax protein, and metabolic differences caused by
growth on different carbon sources, as well as different genetic
backgrounds of the various strains used in the studies
[41,109,110,119,120]. For instance, Priault et al. demonstrate a
markedly reduced level of cyt c release induced by expressing
Bax under the control of the tetracycline-responsive tetO
promoter, as compared to the much stronger GAL10 promo-
ter [120]. Also, numerous reports describe the distinct effects
of Bax when yeast cells are cultured in fermentative, semi-
fermentative, or solely respiratory growth-dependent conditions
[25,95,119]. Therefore, a careful examination of the growth
conditions is important when comparing studies on the events
associated with the expression of Bax in yeast and their genetic
determinants.
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togenic factors from isolated mitochondria, is prevented upon
pharmacological inhibition of the PTPC in mammalian cells
[121]. Further, Bax interacts specifically with the ANTsubunit of
the PTPC in the two-hybrid system and the two proteins co-
immunoprecipitate at endogenously expressed levels in HT-29
cells. There appears also to be a requirement for a functional
interaction between Bax and the ANT, since Bax-deficient cells
are unresponsive to a PTCP-activating ANT ligand [110].
In support of these observations, yeast cells lacking the three
ANT-encoding genes were markedly resistant to the negative
effect on clonogenicity induced by LexA-fused Bax expressed
under the control of theGAL10 promoter [115]. This suggests that
Bax acts to kill yeast in a conserved ANT-dependent mechanism.
Contrasting to these suggestions that the effects of Bax are
mediated through ANT, the overexpression of ANT-1 induces
apoptosis in mammalian cells, but does not affect the growth of
yeast cells [122]. In addition, yeast lacking ANT display levels
of Bax-induced apoptotic phenotypes, including cyt c release,
profiles of ΔΨm, dissipation, and the MPT hallmark of mi-
tochondrial swelling, that were unaltered when compared to
wild type cells [123]. Also, ANT-deficient cells exhibit wild
type kinetics of loss of clonogenicity upon induction of Bax
[124]. Lastly, it should be noted that an examination of the
effects of Bax on protein import into the mitochondria revealed
that cells co-expressing Bax and ANT-GFP displayed decreased
mitochondrial fluorescence when compared to cells expressing
either ANT-GFP alone or Bax co-expressed with a mitochon-
drial protein (Mtp1p) that is imported though a distinct me-
chanism [124]. These findings lead the authors to posit that Bax
may act to prevent, specifically, the import of mitochondrial
carrier proteins.
Concerning the model of PTPC-mediated release of apop-
togenic factors, there are data that suggest that, rather than ANT,
alternate subunits of the complex are important in the process
[76,77]. The aforementioned study in which the presence of
ANT had no effect on mitochondrial effects of Bax had been
preceded by an elegant demonstration of a direct action of
Bax on VDAC in synthetic liposome preparations [125]. The
authors followed these observations up by showing a sig-
nificantly reduced ability of Bax to induce mitochondrial
dysfunction and cyt c release in whole yeast cells and isolated
organelles deficient in VDAC [123]. Similarly, an investigation
of the mechanisms of apoptosis induced by the pro-apoptotic
Bcl-2 member Bim included studies on isolated yeast mito-
chondria from VDAC1-deficient cells, wherein Bim was found
to promote cyt c release and loss ofΔΨm in a manner dependent
on VDAC1 [126].
These results are in contrast to the findings of Priault et al.
who demonstrated Bax-mediated cyt c release in the absence of
VDAC [109,120]. Interestingly, a strain lacking the VDAC-
encoding POR1 gene displayed more pronounced Bax-induced
effects, suggesting that VDAC may in fact interfere with the
toxic function of Bax [118]. Also, a comparative analysis of
expression levels indicated that the minimum amount of Bax
protein detected in cells undergoing Bax-mediated cell death is
nearly 200-fold less than the amount of VDAC present in theOMM [41]. A recent report that VDAC1, and additionally
VDAC2, are not essential for the effects of Bax in yeast was
published recently by Szklarz et al. while employing a func-
tional genomics approach to identify genes that are necessary
for the Bax-mediated release of mitochondrial proteins [127].
Very recently, using mitochondria isolated from VDAC-defi-
cient cells, an additional study included the finding that VDAC
is dispensible for the tcBid/Bax-induced release of cyt c [43].
These findings have been corroborated by strong evidence
indicating that mammalian cells lacking VDAC display profiles
of stress-induced MPT, cyt c release, caspase cleavage, and cell
death that are indistinguishable, and in some cases exacerbated
when compared to wild type cells [117].
3.3.2. Bax-mediated OMM pore formation independent of
endogenous mitochondrial proteins
A number of observations are suggestive of an independent
pore-forming role for Bax leading to the release of intermem-
brane space proteins. The structure of some of the Bcl-2 family
members display similarity to pore-forming bacterial toxins and
are able to form ion channels in synthetic membranes [128,129].
In particular, oligomeric Bax can insert into membranes and
allow the release of cyt c [130]. The mitochondrial apoptosis-
induced channel (MAC) is a high conductance ion channel,
distinct from VDAC, that is induced by apoptotic stimuli [131].
MAC was found to share similarities with Bax-formed chan-
nels, and its formation is inhibited by Bcl-2 expression. In-
terestingly, MAC channel activity was detected in mitochondria
from Bax-expressing yeast cells, confirming a correlation bet-
ween the presence of Bax at the mitochondria and MAC chan-
nel activity [131]. Therefore, Bax promotes the formation of an
ion channel in both mammalian and yeast mitochondria that is
capable of releasing cyt c.
Further evidence for self-sufficient pore-forming action of
Bax emerged from the recent examination of the role of protein
import machineries, including Translocase of the Outer Mem-
brane (TOM) and Sorting and Assembly Machinery (SAM)
complexes, in the Bax-mediated release of mitochondrial fac-
tors [127]. The import of nascent mitochondrial proteins into
isolated yeast mitochondria was unaffected by the induction
of mitochondrial protein release by Bax. Further, mitochon-
dria either treated with protease or isolated from cells lacking
different components of the mitochondrial fission, fusion, or
pre-protein import machinery display a robust release of
mitochondrial proteins in response to Bax expression. These
results clearly show that the Bax-induced release of yeast
intermembrane space proteins occurs while the protein import
into the mitochondrial matrix ensues and suggests that it is
independent of endogenous mitochondrial proteins [127].
Surprisingly, the pore diameter analyses in this study allowed
the release of cytochrome b1 complex, a 230 kDa multisubunit
structure roughly 10-fold larger than the capacity of the Bax-
induced MAC-like channel described above [131]. These data
are also inconsistent with the previously described finding that a
GFP-tagged cyt c, a fusion protein that is less than 230 kDa in
size, is not released into the cytosol upon Bax expression [111].
Thus, while there are data to suggest a pore-forming role for
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chemical and biophysical properties of the pore are likely
modulated by membrane constituents, potentially explaining
the differences observed by groups using custom membrane
preparations [123].
3.4. The role of oxidative stress in Bax-mediated yeast
apoptosis
Reactive oxygen species (ROS) are natural products of ae-
robic metabolism that mediate an array of biological effects,
including inflammatory and immune responses, proliferation,
cellular senescence, and by virtue of their damaging effects on
all classes of cellular material, necrosis [76]. In addition, oxi-
dative stress, caused by elevations in intracellular ROS levels, is
a central mediator of apoptosis in most, if not all, cell types
examined, including yeast [77]. The evidence for a role for
oxidative stress in yeast apoptosis includes the analysis of ap-
optotic responses in cells lacking or overexpressing genes en-
coding proteins preventing oxidative stress and observations
that exogenous anti-oxidants protect from apoptosis [54]. Fur-
ther, the detection of elevations in intracellular ROS in yeast
has been observed in response to a variety of apoptotic stimuli,
such as acetic acid and Bax expression [21,107].
Madeo et al. demonstrated that elevations in intracellular
ROS were necessary and sufficient to induce apoptosis in yeast
providing a strong argument for an evolutionarily conserved
consequence of stress-induced oxidative stress [21]. In addition,
the authors demonstrated that the accumulation of ROS induced
by Bax expression was inhibited by co-expression of Bcl-xL.
Free radical spin traps were also effective in preventing the Bax-
induced apoptotic events, including chromatin condensation,
DNA strand breakage, and cell death. Bax-induced ROS accu-
mulation is not observed in a [rho0] strain and is dependent on
genes encoding specific components of the respiratory chain,
including VDAC and cyt c [110]. These results are in agreement
with prior studies [119,120], which demonstrated that the lethal
effects of Bax were markedly less severe when yeasts are
grown under anaerobic conditions. Additionally, a number of
subsequent findings strongly suggested that Bax-induced apop-
tosis is mediated through elevations in ROS leading to oxida-
tive stress and have been substantiated by subsequent reports
[64,67,69,132].
In addition to oxidative stress caused by the accumulation of
ROS, alternate oxidative pathways exist that have been sug-
gested to mediate apoptotic responses in response to stressful
stimuli [133]. The involvement of alternate oxidative processes
in apoptosis has also been documented in yeast expressing Bax.
For instance, Bax expression markedly reduced both the total
amount of mitochondrial fatty acids and the ratio of unsaturated/
saturated fatty acids, and that these changes were due to mi-
tochondrial lipid peroxidation [119]. The incorporation of exo-
genous fatty acids promoted Bax-induced lethality and treatment
with inhibitors of lipid peroxidation prevented Bax-induced cell
death, suggesting that lipid peroxidation is a direct mediator of
Bax-induced lethality. Despite chemical scavenging of Bax-
induced ROS, the Bax-induced effect on lipid peroxidationpersisted, suggesting that lipid peroxidation is not a consequence
of Bax-induced ROS generation, but rather one of lipid-oxidizing
enzyme activation.
The mechanism by which Bax promotes ROS accumulation
remains unknown. Attempting to address this, Reekmans et al.
reasoned that H2O2 treatment likely generates ROS directly,
bypassing the mechanisms by which Bax-induced ROS for-
mation occurs [134]. Therefore, transcripts differentially
regulated by Bax expression, but not by an equally toxic dose
of H2O2, represent candidate proteins acting to mediate ROS
formation induced specifically by Bax. Using microarray- and
RT-PCR-based strategies, the authors confirmed a Bax-specific
transcriptional response for 4 genes (MLS1, OYE3, ICY2, and
BTN2). Following the rationale outlined above, strains lacking
these genes were predicted to be defective in the pro-oxidant and
lethal effects of Bax. Indeed, the OYE3 gene, encoding an
NADPH dehydrogenase for an unknown substrate, was re-
quired for Bax-induced cell death. Further, while Bax-induced
membrane lipid peroxidation was impaired in the Δoye3 strain,
H2O2-induced cell death and lipid peroxidation responses were
exacerbated. These results further supported a role for lipid
peroxidation in the effects of Bax, and suggested that OYE3
regulates Bax-induced accumulation of ROS.
The critical role of ROS accumulation and oxidative stress
inreceived in revised form Bax-mediated yeast apoptosis dis-
cussed above has been substantiated by subsequent findings
from other groups [64,66,69]. Cells possess a variety of me-
chanisms that protect from oxidative stress, including the
enzymatic modulation of ROS directly (i.e. by catalases, super-
oxide dismutases, or peroxidases), as well as the regulation of
the redox state of the intracellular milieu through anti-oxidants
(i.e. glutathione, thioredoxin) [38,77]. Further support for the
hypothesis that oxidative stress is critical for Bax-induced yeast
apoptosis is provided by studies on the isolation of suppressors
of Bax-induced cell death that function directly in the oxidative
stress defense systems, including the soybean APX, and the
tomatoGST/GPX and PHGPx (see also Section 2.3.3) [65,69,78].
In addition to providing insight into Bax function, the GST/
GPX prevented Bax-induced reductions in intracellular glu-
tathione levels, suggesting that glutathione depletion is a me-
chanism by which Bax promotes lethality [78]. It should be
noted also that 4 of the 6 Bax-suppressive clones identified in
the report describing the GST/GPX were homologues of known
anti-oxidant proteins [78]. Finally, the tomato QM protein
acts to promote accumulation of antioxidative proline, thereby
preventing oxidative stress [135]. This protein confers protec-
tion from Bax-induced ROS accumulation and reductions in
viability, supporting the hypothesis that ROS mediate the lethal
effects of Bax. These findings collectively underscore the
importance of oxidative stress defense systems in the response
to Bax.
3.5. Oxidative phosphorylation in Bax-mediated yeast
apoptosis
It is clear that Bax-mediated apoptosis involves the action of
the protein at mammalian mitochondria. Early investigations
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the yeast mitochondria for Bax-induced lethality, but not for
growth-inhibition [25]. While wild type cells displayed a loss in
viability in response to the induction of Bax, cells lacking a
mitochondrial genome ([rho0], or ‘petites’) were completely
resistant to these effects. Subsequent works toward identifying
the genetic determinants of Bax-mediated cell death have re-
peatedly indicated an important role for the oxidative phospho-
rylation machinery and respiratory status in Bax-mediated
yeast apoptosis [75,118,136]. These studies further exemplify
the amenability of yeast to functional genomics approaches, and
provide additional examples as to the advantages of using a
facultative aerobe in the study of the mitochondrial mechanisms
of Bax-mediated apoptosis, since interfering with oxidative
phosphorylation in mammalian cells results in lethality. For
instance, ATP4, a nuclear gene encoding a critical subunit of
the F1–F0 proton pump (F1–F0–ATPase), was isolated in a
screen for yeast mutants resistant to Bax-mediated lethality
[75]. The examination of haploid and heterozygous diploids
lacking ATP4 revealed a requirement of the gene for Bax-
induced lethality. Pharmacological inhibition of the F1–F0–
ATPase also abrogated the lethal effects of Bax, confirming
the requirement of a functional Atp4p-containing proton pump.
Finally, while Bax-induced death was completely abrogated in
cells mutated for an additional component of the F1–F0–ATPase
(ATPδ), the kinetics of death were shown to be only markedly
delayed (not completely abrogated) in [rho0] cells. The absolute
requirement of F1–F0–ATPase function (of which partial ac-
tivity is maintained in [rho0] cells), but not that of the mito-
chondrial genome, suggests a specific requirement for the
proton pump, and not a general dependency on respiratory
competence. Supporting such a conclusion, studies in mamma-
lian cells demonstrated a protection from Bax-dependent
apoptosis by sublethal doses of an F1–F0–ATPase inhibitor,
but not by inhibition of an alternate complex of the respiratory
chain [75].
Direct evidence for a pH-regulated, ATP4-dependent me-
chanism in the effects of Bax in yeast was obtained by using a
pH-sensitive mutant of GFP (pH-GFP) that responds to chan-
ges in pH between 7.0 and 8.5 by nearly linear increases in
fluorescence emissions [136]. Changes in emission profiles
of a mitochondrial matrix targeted pH-GFP indicated a Bax-
induced alkalinization of yeast mitochondria in wild type
cells that was not observed in cells lacking ATP4. In addi-
tion, there was a concomitant ATP4-dependent cytosolic aci-
dification upon expression of Bax. The authors of these studies
posit that changes in the IMM potential or of the pH in the
intermembrane space due to the deficiency of the proton pump
interfered with the insertion of Bax into the membrane or Bax
channel activity.
In addition to confirming the importance of ATP4, further
evidence indicating a role for oxidative phosphorylation is
provided from the analysis of Bax-mediated lethality in a
panel of strains deficient in specific mitochondrial protein-en-
coding genes [118]. Strains lacking genes essential for growth
on non-fermentative carbon sources (i.e. COX4, ATP4, PET9,
CYC3, COX7, QCR7, as well as [rho0]) displayed significantlyincreased resistance to the deleterious effects of Bax, whereas
strains that retained respiratory competence (i.e. those lacking
SDH3 and NDI1) responded similar to wild type. An additional
independent study indicated that cells lacking ATP4 and ATP2
displayed a dramatic resistance to Bax-induced cell death [110].
Further, a permanent respiratory defect due to inhibition of
oxidative phosphorylation is a direct consequence of Bax in-
duction [118,124]. These are compelling arguments suppor-
ting the notion that Bax in yeast, as mammalian cells, functions
to promote specific alterations in mitochondrial physiology
and function [118].
Given the central role of the mitochondria in apoptosis, one
might expect the respiratory status of the cell to modulate the
response to Bax expression. Priault et al. demonstrated that the
extent to which Bax expression induces cell death is directly
related to the respiratory ability of yeast [120]. This is reconciled
with findings that high cytosolic ATP/ADP ratios (present in
respiring cells) promote the cytotoxic effects of Bax [104].
However, cells grown in fermentative conditions are also kil-
led upon expression of Bax, albeit with a significantly delayed
response. These data argue for a cell death-promoting function
for Bax independent of oxidative phosphorylation. This notion is
consistent with an examination by Kissova et al. that revealed
that both ANT-deficient and [rho0] strains displayed wild type
rates of Bax-induced loss of clonogenicity [124].
In addition to cyt c, Manon et al. reported a decrease in the
amount of cytochrome aa3, and therefore a decrease in cyt
c oxidase complex in response to Bax expression [104]. Sub-
sequent reports indicated a decrease in the level of cyt c oxidase
present at the IMM as a consequence of Bax expression [137].
This decrease was later found to be the result of degradation
of a cox subunit, cox2p, through the action of a Bax-activated
protease termed Yme1p. Interestingly, Bax-mediated cell death
is delayed in cells lacking YME1, suggesting that Bax-mediated
apoptosis occurs through decreasing the levels of Cox2p. Cell
death is not abrogated, however, indicating alternate pathways of
cell death execution and possibly reflecting a preference for
distinct pathways used for apoptosis depending on respiratory
status.
4. Bax expression in yeast elicits pleiotropic effects
Upon expression in yeast, Bax localizes to mitochondria
and alters the physiology of this organelle in a manner com-
parable to the effects of Bax in metazoan systems [23]. A
specific role for Bax at the mitochondria leading to apoptosis
has been supported by a number of observations using whole
cells, as well as purified mitochondria. These include many of
the observations discussed above, such as the protective ability
of anti-apoptotic Bcl-2 family members, and both microscopic
and biochemical demonstrations that Bax undergoes regulated
localization to mitochondria [23]. While Bax expression in
yeast is clearly sufficient to induce yeast apoptosis, alternative
hypotheses have emerged that question the specificity with
regard to the function of Bax in yeast. For instance,
heterologous expression of Bcl-2 can alleviate the oxidant
hypersensitivity of yeast cells lacking the gene encoding
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protective function independent of Bax [36]. Thus, while the
Bax-suppressive functions of anti-apoptotic Bcl-2 proteins may
indeed reflect specific modes of killing, it is difficult to
determine the contribution of their innate anti-oxidant activity in
these effects. Additionally, in contrast to reports in mammalian
cells describing the activation of Bax by stress-induced ROS
generation [138], the production of endogenous ROS in yeast
appears to be a downstream effect of Bax function [10],
analogous to what is observed in yeast challenged with
exogenous stressful stimulus.
A number of groups have reported alternative phenotypes
associated with Bax expression in yeast, such as Bax-induced
alterations in vacuolar and protein transport pathways, auto-
phagy, and mitophagy [139–141]. Certain suppressor screens
have indicated that Bax displays pleiotropic effects. For ins-
tance, an evolutionarily conserved suppressor of the effects of
Bax in yeast (BI-1) has functions at the ER [142,143], sug-
gesting a mitochondria-independent pathway of Bax-mediated
apoptosis. It should be noted that apoptosis in mammalian cells
has been reported as a consequence of ER-localized Bax andBak
proteins [144]. Further, a screen for yeast mutant displaying
resistance to the lethal effects of Bax expression identified
UTH1, a gene that was also shown to be required for rapamycin-
induced autophagy [145]. These observations suggest that Bax
expression in yeast may induce a stress response not exclusive to
the mitochondria and thereby mediate pleiotropic effects. Below
we review further evidence for the pleiotropic effects of Bax
expression in yeast.
4.1. The effects of Bax are independent of canonical pro-
apoptotic regulators
The identification of a caspase-like protein encoded by
the YCA1 gene represents a seminal discovery in the study of
yeast apoptosis, providing support for the notion that molecular
pathways that are conserved between higher eukaryotes mediate
the apoptotic programme [12]. YCA1 is one of a growing
number of yeast genes, including AIF1, NMA111, and NUC1,
with apoptotic roles in response to different apoptotic stimuli,
such as H2O2, acetic acid, heat stress, osmolarity, and aging [11–
13,146]. Early analyses indicated that Bax-mediated lethality
in yeast is unaffected by the co-expression of the cowpox virus-
encoded CrmA, a known inhibitor of caspase activity [39].
Consistently, it was subsequently reported that Bax-induced cell
death occurs independent of YCA1 (MCA1) [46] and that the
lack of YCA1 had no effect on the loss of plating efficiency
induced by Bax expression [147]. Furthermore, cells deficient
in the pro-apoptotic AIF1 gene unexpectedly exhibited more
pronounced losses of plating efficiency as compared to wild
type cells [147]. In addition, no detectable increase in caspase
activity is detected in response to Bax induction. Therefore, the
effects of Bax on cell death in yeast appear to be independent of
the canonical apoptotic mediators. It should be noted, however,
that caspase-independent apoptosis in response to a variety of
stimuli, including Bax expression, has also been reported in
mammalian systems [148,149].4.2. Bax expression promotes plasma membrane integrity
Bax expression in yeast prevents the ethanol-induced per-
meabilization of the plasma membrane observed during in-
duction of apoptosis under fermentative conditions [150]. This
extra-mitochondrial effect of Bax parallels the maintenance
of mammalian plasma membrane integrity that distinguishes
apoptotic from necrotic cell death. Recently, the maintenance of
plasma membrane integrity by Bax was found to be indepen-
dent of both YCA1 and AIF1, suggesting that the effect is not
mediated through the apoptotic programme [147].
4.3. Bax overexpression induces autophagic cell death and
mitophagy
Autophagy is a genetically programmed process whereby
portions of the cytoplasm are enveloped by double-bilayer
vesicles (autophagosomes) and delivered to the vacuole. This
leads to the ultimate degradation of the autophagosomal con-
tents and is thought to serve the purpose of nutrient recycling
during periods of starvation [151]. Accumulating evidence
suggests a role for autophagy in the regulated degradation of
whole organelles to promote adaptation to different growth
conditions [151]. For instance, the selective removal of mi-
tochondria occurs through a specialized form of autophagy,
termed mitophagy [152]. By promoting adaptation in times of
stress, therefore, autophagy is thought to promote cell viability. A
seemingly contradictory notion has emerged of late through the
analysis ofmorphologic and genetic data suggesting an active role
for autophagy in programmed cell death. One model stemming
from work in both yeast and mammalian cells posits that while a
low-level of autophagy is indeed protective, an increased level
may serve to promote death [153]. However in the absence of clear
molecular signals that would regulate such a transition, autophagy
is not considered a bona fide programmed cell death process, but
is denoted as “programmed cell death with autophagy” [154].
Some reports also describe a caspase-independent form of
programmed cell death associated with extensive autophagocy-
tosis as Type II cell death, whereas the traditional characteristics of
apoptosis define Type I cell death [155].
Initial visualizations of yeast cells expressing Bax using
electron microscopy (EM) indicated the presence of autopha-
gic, rather than apoptotic, phenotypes, such as vacuolarization
[30]. Further, the genetic determinants of autophagy have been
shown to co-regulate apoptotic responses in both yeast and
mammalian cells in some conditions. For instance, the
induction of the human ortholog of APG5, a gene that is
necessary for autophagosome formation in yeast and mamma-
lian cells, is induced by apoptotic stimuli [156]. Also, the anti-
apoptotic Bcl-2 protein displays anti-autophagic effects in both
yeast and mammalian cells [153]. Autophagic and apoptotic
programmed cell death responses are indeed distinct, however,
because the former can lead to a loss of cell viability in the
absence of hallmarks associated with the latter, and vice-versa
[154]. It has been proposed that it is the extent to which the
autophagic programme is induced that determines the ultimate
effect on cell viability [153].
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inducing effects of Bax?
Identified in a screen for mutants displaying resistance to
Bax-induced cell death, the UTH1 gene encodes for an OMM-
localized protein that represents a potential molecular determi-
nant of apoptotic or autophagic effects of Bax [145]. In strains
deleted for UTH1, Bax is targeted to the mitochondria and
retains the ability to promote cyt c release. However, additional
phenotypes that are crucial for Bax-induced apoptosis, including
effects on lipid peroxidation, ROS production, and plasma
membrane stability, displayed a dependency on the presence of
UTH1. Also, expression ofUTH1 under the control of theGAL1
promoter was sufficient to promote cell death. These data
indicate a critical role for UTH1 in the programmed cell death
response to Bax expression in yeast.
Observations that Δuth1 cells are resistant to the deleterious
effects of other stressful stimuli such as H2O2, carbon and
nitrogen starvation, and elevated temperatures [157], prompted
the examination of the role of Uth1p in programmed cell
death with autophagy. Interestingly, cells lacking UTH1 are
resistant to the APG5-dependent decrease in viability induced
by rapamycin, indicating that Uth1p may function to prevent
autophagy [145]. Further, this phenotype is observed only when
cells are grown on respiratory carbon sources, indicating the
requirement for mitochondria in the protection against auto-
phagy-mediated cell death.
A recent report indicated primarily autophagic, rather than
apoptotic, phenotypes concomitant with loss of plating
efficiency induced by Bax [147]. These phenotypes included
increased accumulation of Atg8p, activation of a vacuolar
alkaline phosphatase, and the detection of autophagosomes
and autophagic bodies by EM. Bcl-2 or Bcl-xL co-expression
prevented the autophagic characteristics of Bax expression.
Strains deleted for genes essential to the process of autophagy
(ATG4, ATG5, ATG7, ATG8, ATG15, ATG16), however,
displayed either similar or more pronounced rates of clono-
genicity. Therefore, while Bax induces autophagy, the autopha-
gic process is not necessary for the Bax-induced loss of plating
efficiency.
A previous study suggested that UTH1 mediates the pro-
cess of selective mitochondrial autophagy, but does not exert
effects on cytosolic autophagy [152]. Given the role of UTH1 in
Bax-induced programmed cell death, a role for the process of
mitophagy in the effects of Bax was examined [147]. Vi-
sualization of a fluorescent mitochondrial probe revealed a
more pronounced Bax-induced fragmentation of the mitochon-
drial network in a Δuth1 strain as compared to wild type cells.
Furthermore mitophagy-dependent degradation of the mito-
chondria induced by Bax expression is abrogated in cells
deficient in UTH1. These results suggested that Uth1p is in-
volved in mediating the mitophagic effects of Bax [147].
4.3.2. Bax expression leads to vacuolar defects
In addition to changes at the mitochondria, Bax expression
in yeast has been reported to induce alterations in vacuolar
morphology [139]. This was noted upon analysis of a strain
carrying a mutant allele of the ARL1 gene that is defective incentral vacuole formation and membrane trafficking resulting in a
delay of programmed cell death with autophagy. This strain was
also resistant to cell death induced by Bax expression.
Ultrastructural analysis revealed that Bax expression induced
autophagic hallmarks that were not observed in the strain mutated
at the ARL1 locus. Also, Bax-induced apoptotic features,
including membrane blebbing and chromatin condensation,
were more pronounced in strains that were defective in central
vacuole formation (i.e. mutated at ARL1) [139]. These data
suggest that while Bax expression induces both apoptosis and cell
death with autophagy, the latter may be a default outcome.
Further evidence for pleiotropic effects of Bax in yeast came
from a screen for yeast mutants displaying resistance to the lethal
effects of Bax [158]. This resulted in the isolation of 12 Bax-
resistant strains thatwere able to growon non-fermentative carbon
sources, indicating that the phenotype was not due to respiratory
defects [158]. Supporting the observations that resistance toBax is
conferred by defects in autophagic and membrane trafficking
processes, 8 of the 12 mutants displayed decreased viability in
conditions promoting nutrient recycling (i.e. after an incubation
period in nitrogen-deprived media). The majority of the Bax-
resistant strains also failed to exhibit changes in mitochondrial
physiology that are readily observed upon Bax expression in wild
type cells (i.e. hyperpolarization and subsequent depletion of
ΔΨm). Notably, while most mutants displayed reduced Bax-
induced rupture and eventual loss of vacuolar structures, one strain
(R6 strain) showed pronounced changes in vacuolar architecture.
A set of suppressors of the Bax-resistant phenotype observed in
the R6 strain, was found to consist of known components of
protein transport stress response machineries. These suppressors
promoted Bax-induced disruption of the vacuole, but left the
mitochondria unaffected. This indicates that the mechanism by
which these suppressors promote Bax sensitivity in the R6 strain is
independent of the mitochondria.
A further demonstration that the vacuolar defects associated
with Bax expression are independent of apoptosis-inducing effects
of Bax on mitochondria comes from a study of the Bax-Inhibiting-
Glutathione S-transferase (BI-GST) protein, isolated as a high-copy
suppressor screen from a tomato cDNA library [78,159]. BI-GST
expression confers protection from the effects of Bax, as well as the
effects of pro-oxidants in a YAP1-dependent manner. Interestingly,
while co-expression of Bcl-2 was expectedly sufficient to reverse
the mitochondrial defects induced by Bax, the vacuolar alterations
persisted. In contrast, Bax-induced aberrant cargo sorting pheno-
type and vacuolar changes were rescued in cells co-expressing BI-
GST. These findings suggest that Bax also has distinctly different
functions at the mitochondria and the vacuole.
4.3.3. Bax Inhibitor-1: Further evidence for pleiotropic effects
of Bax
Xu and Reed, using a functional lethality screen of a hu-
manHepG2 cDNA expression library, identified Bax Inhibitor-1
(BI-1) as the first reported heterologous suppressor of Bax-
induced cell death in yeast [59]. This report also demonstrated
that BI-1, overexpressed in mammalian cells, is protective from
a variety apoptotic stimuli and that its depletion induces apop-
tosis in HEK293.While human and rat BI-1 had been previously
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cytoprotective activity. Orthologs of BI-1 have been shown to
possess anti-apoptotic functions across the animal, plant and
fungal kingdoms [160]. Interestingly, the Arabidopsis thaliana
BI-1 ortholog (AtBI-1), is capable of suppressing Bax-induced
cell death in yeast indicating the ancient evolutionary origins of
its anti-apoptotic function [161]. Surprisingly, AtBI-1 has been
proposed to act as a dominant negative inhibitor of mamma-
lian BI-1, based on a report of its pro-apoptotic activity upon
heterologous expression in human fibrosarcoma HT1098 cells
[162]. AtBI-1-induced apoptosis in these cells can be prevented
by human BI-1, Bcl-xL, or XIAP co-expression [162]. While
this study suggests that the mechanisms of BI-1 function are
distinct between yeast and mammalian cells, other plant or-
thologs of BI-1, such as from tobacco and oilseed rape, are
clearly anti-apoptotic in HEK293 cells [163]. Future studies are
needed to resolve this discrepancy and would shed further light
on the molecular mechanisms of BI-1 function.
Early observations discussed in the study by Xu and Reed
also suggested a predominantly ER localization for human BI-1
and were thereafter confirmed in both plant and mammalian
cells expressing plant orthologs of BI-1 [163,164]. Interestingly,
heterologous expression of AtBI-1 clusters predominantly at the
perinuclear region in yeast, suggesting a similar ER localization
[164]. Providing strong evidence for the evolutionarily con-
served nature of BI-1 function, Ihara-Ohori et al. demonstrated
an interaction between AtBI-1 and the ER-resident, Ca2+-
handling protein calmodulin in both yeast and plant cells [142].
AtBI-1 mutants unable to interact with calmodulin display no
anti-apoptotic activity in yeast, suggesting a requirement for
the interaction. Further, this study shows that AtBI-1 serves to
regulate stress-induced Ca2+ ion fluctuations, and that its anti-
apoptotic function in yeast is dependent on PMR1 and SPF1,
genes encoding Ca2+ pumps which are essential for maintaining
ion homeostasis [142]. This is in line with evidence indicating a
causal role for ion imbalance in mammalian cell apoptosis [165].
The functional characterization of suppressors of Bax-indu-
ced apoptosis can reveal insight into the mechanisms of Bax-
mediated apoptosis in yeast. Collectively, the studies of BI-1
function in yeast suggest that Bax-mediated cell death in yeast
involves elevations in Ca2+ levels, a commonly observed res-
ponse to many cellular stresses [142]. The subcellular localiza-
tion of BI-1 is also suggestive of mitochondrial-independent
consequences of Bax expression, with effects likely impin-
ging on the endoplasmic reticulum [61]. It is of note that Bax-
mediated cyt c release is dependent on elevations in ER
and mitochondrial Ca2+ levels. Therefore, we may speculate
that BI-1 acts upstream of Bax in yeast to limit its ability to
release cyt c, however this remains to be tested. Nevertheless,
the BI-1 protein is an exemplary case of the mechanistic insight
that can be gained by the continued study of a heterologous
suppressor of Bax-mediated apoptosis in yeast.
5. Conclusions and perspectives
Early indications that heterologous metazoan Bcl-2 proteins
have similar pro- and anti-apoptotic functions in yeast werelargely viewed as artifact. In effect, it has been known for a long
time that the expression of numerous heterologous genes in yeast
often leads to slow growth and/or cell death likely due to non
specific effects believed to be caused by the sheer levels of
expression that can be achieved in yeast [166]. Creating further
skepticism, yeast lacks endogenous Bcl-2 proteins and was
not known to undergo any process resembling apoptosis. The
continued study of Bax, coupled to a growing awareness that
yeast cells undergo a genetically encoded form of program-
med cell death that resembles metazoan apoptosis, has led to an
explosion in the study of Bax in yeast. As elaborated here, these
studies have increased our understanding of the structure and
function of Bax, as well as increased our understanding of the
apparent complexity by which Bax functions to kill cells. For
example, genetic screens for suppressors of Bax-mediated yeast
cell death and endogenous yeast genes that are required for Bax
to kill yeast cells has led to the suggestion that processes
as diverse as lipid peroxidation, ROS elevation, and ceramide
generation are critically involved in the process of yeast apop-
tosis. The lack of Bcl-2 orthologues in yeast suggests that Bax
functions by impinging on components of a conserved apoptotic
network. Alternatively, it is tempting to speculate that yeast
may contain functional Bax-like proteins, which like the recently
recognized yeast metacaspase Yca1p, are not obviously similar
to metazoan Bcl-2 proteins. In either case, the study of the Bax
in yeast is likely to remain a rich field that will likely give fresh
insight into these proteins and yeast apoptosis.
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